Pathophysiology in the Failing Heart
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Medicine".
Deadline for manuscript submissions: closed (10 June 2023) | Viewed by 8778
Special Issue Editors
Interests: ischaemic heart disease, heart failure, echocardiography, pulmonary hypertension
Special Issue Information
Dear Colleagues,
We are pleased to invite you to take part in this Special Issue of Biomolecules dedicated to heart failure and its pathophysiology.
Heart failure is a growing medical and social problem. The number of patients being treated for heart failure is steadily increasing. It seems important to search for markers allowing the estimation of the survival of heart failure patients. The development of research on cardiovascular pathophysiology should have an impact on clinical management. Currently, the main biochemical parameter used by clinicians is NTproBNP. Finding new markers affecting prognosis may improve patient management, reduce hospitalizations and improve patient quality of life.
This Special Issue will focus on the pathophysiological processes of heart failure, the understanding of which will have an impact on prognosis.
In this Special Issue, original research and review articles are welcome. Research areas may include (but are not limited to): unknown pathophysiological processes leading to heart failure, as well as new promising biomarkers and treatment options.
We look forward to receiving your contributions.
Prof. Małgorzata Knapp
Prof. Dr. Jerzy Beltowski
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- heart failure
- pathophysiology
- biomarkers
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.